SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
URMD -- Huge market potential
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
369 4 0 URMDD
Emcee:  Tom Wilson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
144 Hey George; Thanks for understanding fella. JoeJoe Sing-11/14/1997
143 Jim; They said that the stock is finally gaining momentum. The market seems to Samuel J. Bennett-11/14/1997
142 Sam, What is Individual Investor saying about URMD?? Do you really think itJim Hostetler-11/13/1997
141 Thanks Joe; I bought another 1000 shares at $5 3/8...I'll bet with a companSamuel J. Bennett-11/13/1997
140 Joe, I was not at all offended by what you had to say about Uromed, in fact I george-11/13/1997
139 George, Sorry to be so aggressive, but it genuinely bothers me when possibly Joe Sing-11/13/1997
138 Joe, I am impressed by your hard nosed approach to URMD. Can you give me the nageorge-11/11/1997
137 With five FDA approved products and $80 million in cash, URMD is more than a deTheCat-11/11/1997
136 Joe; This is a development stage company. Let it develop. If you don't likSamuel J. Bennett-11/10/1997
135 Hi Jeff: Sour Grapes? NOPE, Just Sour Sales! Sour Revenues! Sour Earnings! SoJoe Sing-11/10/1997
134 I sure wish this market would calm down and let these stocks do their things. Diane Leadman-11/10/1997
133 Hello; The time to buy was at $4 1/2 ??? Next year, one might say: the time to Samuel J. Bennett-11/8/1997
132 Justin, You are so right 4 1/2 is better ! At 6 could be the next play when itRay Tarke-11/7/1997
131 The time to buy was at 4 1/2Justin Pressley-11/7/1997
130 Sounds like sour grapes to me. Do you possess the ability to analyze the revenJeff Clegg-11/7/1997
129 SHORT??? ... PROFITS ARE DOWN 20,433% .... AND DOWN EVERY SINGLE QUARTER >&gJoe Sing-11/7/1997
128 More info from IR: Potential Hospitals: 2000 Estimated number of reusable unitRichard Monge-11/7/1997
127 Agreed... a great time to buy.Upgrade coming soon to a strong buy. The news tRay Tarke-11/6/1997
126 Jeff, Montgomery's analyst is estimating the disposable at $3,000. at pop, mattie-11/6/1997
125 Market Potential (from Investors Relations) of CaverMap Aid: U.S. DATA ONLY: #Jeff Clegg-11/6/1997
124 >>Ken do you know what the average revenue per procedure will be for URMDKen M-11/6/1997
123 Ken do you know what the average revenue per procedure will be for URMD and whaRichard Monge-11/6/1997
122 Uromed (NASDAQ:URMD) CaverMap Aid gets FDA approval Reuters, Thursday, NovembeKen M-11/6/1997
121 Joe, Your points make sense, but just remember that Uromed is not about earninggeorge-10/22/1997
120 Mattie, the reasons for Soros buying into UroMed have more to do with his peoplJoe Sing-10/22/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News